Ignite Creation Date:
2024-05-05 @ 11:40 PM
Last Modification Date:
2024-10-26 @ 10:37 AM
Study NCT ID:
NCT01383811
Status:
COMPLETED
Last Update Posted:
2014-03-06
First Post:
2011-06-23
Brief Title:
Exercise in Treatment Resistant Depression TRD A Feasibility Study
Sponsor:
Milton S Hershey Medical Center
Organization:
Milton S Hershey Medical Center
Study Overview
Official Title:
Clinical and NeuroendocrineMetabolic Benefits of Exercise in Treatment Resistant Depression TRD A Feasibility Study
Status:
COMPLETED
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to determine the effects of adjunct exercise in treatment resistant depression The central hypothesis for the research is that adjunct exercise with usual care in Treatment Resistant Depression TRD will have significant effects in improving the psychiatric symptoms in comparison to usual care alone
Detailed Description:
Participants with treatment resistant depression will be recruited to participate in a 12-week clinical trial on the effects of adjunct moderate-intensity exercise versus usual care Primary outcome measure will be reduction in baseline scores on Hamilton Depression Rating Scale 17 item Secondary outcome measure will include reduction in baseline scores of clinical global impression severity pittsburgh sleep quality index global score scores on beck depression inventory and improvement in actigraphic sleep
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None